BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program
October 31, 2024 07:00 ET
|
BioRestorative Therapies, Inc
– Further expands already formidable intellectual property estate the Company has been building for its novel ThermoStem® technology platform – MELVILLE, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) --...
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
November 16, 2023 08:00 ET
|
NeuroOne Medical Technologies Corp
Patent allowance strengthens IP portfolio and positions company in pursuing drug delivery using its neural probes EDEN PRAIRIE, Minn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical...